In:
Arteriosclerosis, Thrombosis, and Vascular Biology, Ovid Technologies (Wolters Kluwer Health), Vol. 26, No. 4 ( 2006-04), p. 857-863
Kurzfassung:
We show enhanced expression of osteoprotegerin (OPG), RANK, and RANK ligand (RANKL) in clinical and experimental atherosclerosis with enhanced T-cell expression of RANKL as an important feature of unstable disease, further supporting a role for the OPG/RANKL/RANK axis in atherogenesis and plaque destabilization.
Materialart:
Online-Ressource
ISSN:
1079-5642
,
1524-4636
DOI:
10.1161/01.ATV.0000204334.48195.6a
Sprache:
Englisch
Verlag:
Ovid Technologies (Wolters Kluwer Health)
Publikationsdatum:
2006
ZDB Id:
1494427-3
Permalink